MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$12,734,434
Net Income
$830,872
Net Profit Margin
6.52%
Unit: Dollar
Revenue Breakdown
Net Product Revenues
Grant Income
Research And Development Revenue...
Others
Revenue Breakdown
Defense
Grant
Research And Development
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-27
2026-03-28
2025-12-27
2025-09-27
Total revenues
12,734,434
10,551,370
8,367,931
11,962,425
Cost of product revenues
6,587,365
5,609,253
4,733,103
8,397,135
Research and development funded
3,326,842
3,806,233
863,865.75*
-
Research and development internal
1,197,238
1,105,336
127,656
2,502,988
Selling, general and administrative
5,126,655
6,017,411
5,069,631
1,629,175
Litigation damages
-
-
2,591,597.25*
-5,100,000
Total operating expenses
16,238,100
16,538,233
13,385,853
7,429,298
Loss from operations
-3,503,666
-5,986,863
-5,017,922
4,533,127
Interest income
95,489
94,162
280,465*
281,194
Other (expense) income, net
-210,810
-224,613
-82,546
-77,312
Foreign currency transaction gains
22,027
114,335
311,691
-156,774
Gain on deconsolidation of subsidiary
-
-
10,892,417*
-
Gain on investments
2,337,832
2,307,961
474,006
-447,631
Total non-operating income
2,244,538
2,291,845
11,876,033
-400,523
Loss before provision for income taxes
-1,259,128
-3,695,018
6,858,111
4,132,604
Us federal statutory rate amount
-
-
144,750*
-
Tax credis amount
-
-
-1,750*
-
Uncertain tax positions amount
-
-
103,000*
-
Equity compensation awards amount
-
-
-106,250*
-
Compensation amount
-
-
41,500*
-
Non taxable dividends amount
-
-
-8,250*
-
Deconsolidation tax effects amount
-
-
-476,500*
-
Fmv preferred stock forward contract amount
-
-
43,500*
-
Other amount
-
-
-8,250*
-
Fed nol expiration and true up amount
-
-
-36,500*
-
Change in valuation allowance amount
-
-
356,750*
-
Benefit (provision) for income taxes
-2,090,000
57,020
52,000
52,000
Net income (loss)
830,872
-3,752,038
6,763,235.75*
-
Dividends and deemed dividends on series a convertible preferred stock
-
35,000
14,291.75*
-
Net income (loss)
-
-
-
4,080,604
Net loss attributable to common stockholders
-
-3,787,038
6,748,944
-
Basic EPS
0
-0.02
0.036
0.02
Diluted EPS
0
-0.02
0.034
0.02
Basic Average Shares
188,232,764
186,903,857
185,929,858
166,618,201
Diluted Average Shares
192,102,222
186,903,857
198,680,699
169,448,696
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Benefit (provision) for
income taxes
-$2,090,000
(-4119.23%↓ Y/Y)
Gain on investments
$2,337,832
(272574.59%↑ Y/Y)
Interest income
$95,489
(-70.74%↓ Y/Y)
Foreign currency
transaction gains
$22,027
(-31.57%↓ Y/Y)
Net income (loss)
$830,872
Loss before
provision for income taxes
-$1,259,128
(75.38%↑ Y/Y)
Total non-operating
income
$2,244,538
(547.31%↑ Y/Y)
Net Product
Revenues
$7,640,168
(1.89%↑ Y/Y)
Grant Income
$2,598,546
Research And Development
Revenues
$2,168,244
(138.82%↑ Y/Y)
Collaboration Arrangement
Income
$271,478
License And Other
Revenues
$55,998
(15.36%↑ Y/Y)
Other (expense)
income, net
-$210,810
(-1837.24%↓ Y/Y)
Loss from operations
-$3,503,666
(35.85%↑ Y/Y)
Total revenues
$12,734,434
(50.62%↑ Y/Y)
Total operating
expenses
$16,238,100
(16.68%↑ Y/Y)
Cost of product
revenues
$6,587,365
(-6.85%↓ Y/Y)
Selling, general and
administrative
$5,126,655
(4.64%↑ Y/Y)
Research and development
funded
$3,326,842
Research and development
internal
$1,197,238
(-38.46%↓ Y/Y)
Buy us a coffee
KOPIN CORP (KOPN)
KOPIN CORP (KOPN)